NMTC
Neuroone Medical Technologies Corp
NASDAQ: NMTC · HEALTHCARE · MEDICAL DEVICES
$4.70
+0.00% today
Updated 2026-04-30
Market cap
$38.95M
P/E ratio
—
P/S ratio
3.32x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$3 – $7
Volume
0.2M
Neuroone Medical Technologies Corp (NMTC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-58.30%
Operating margin
-59.00%
ROE
-146.30%
ROA
-63.40%
Debt/equity
0.02x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2010 | $1167.00 | $-6044.00 | 100.00% | -517.91% | -517.91% |
| 2011 | $5398.00 | $-27604.00 | 60.39% | -508.11% | -511.37% |
| 2012 | $921.00 | $-13960.00 | 100.00% | -1,491.10% | -1,515.74% |
| 2013 | $921.00 | $-13960.00 | 100.00% | -1,491.10% | -1,515.74% |
| 2014 | $1249.00 | $-30554.00 | 100.00% | -1,571.82% | -2,446.28% |
| 2015 | $773.00 | $-36244.00 | 100.00% | -4,646.05% | -4,688.75% |
| 2016 | $742.00 | $-62863.00 | 100.00% | -4,166.44% | -8,472.10% |
| 2017 | $0.00 | $-47775.00 | — | — | — |
| 2018 | $0.00 | $-6.83M | — | — | — |
| 2019 | $0.00 | $-6.78M | — | — | — |
| 2020 | $1.93M | $-13.64M | 96.34% | -254.46% | -708.00% |
| 2021 | $178146.00 | $-9.95M | -54.87% | -5,735.86% | -5,584.28% |
| 2022 | $171169.00 | $-10.00M | -41.36% | -5,860.15% | -5,841.95% |
| 2023 | $1.95M | $-11.86M | 23.38% | -612.32% | -607.42% |
| 2024 | $3.45M | $-12.32M | 31.27% | -344.26% | -356.74% |
| 2025 | $12.10M | $-3.61M | 67.30% | -34.94% | -29.80% |